ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Three New RFAs Announced In Cancer Control

November 3, 1978

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

In Brief: Donald Metcalf Wins Bristol-Myers Award; NCI Starts Search for Biological Carcinogenesis AD

May 1, 1987

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005